Indian Pharma’s $19.1B US Push Amid Generics Tariff Exemption
🇺🇸 US Imposes 100% Tariff on Patented Drug Imports from India In a major trade policy shift, the United States imposed a 100% tariff on patented pharmaceutical products imported from…
🇺🇸 US Imposes 100% Tariff on Patented Drug Imports from India In a major trade policy shift, the United States imposed a 100% tariff on patented pharmaceutical products imported from…
📋 Why Verification Matters When Sourcing from India India supplies over 20% of the world's generic medicines by volume (GTRI, May 2026) and 60% of global vaccine demand. For international…
How to Safely Import Generic Medicines from India: A 2026 Buyer's Guide India supplies over 20% of the world's generic medicines by volume and 60% of global vaccine demand. For…
Indian generic drugmakers have launched a wave of affordable semaglutide products following the expiry of Novo Nordisk's key patents, with over 50 brands expected in the coming months and prices…